News

Deal Announcements

Metabolex Lands Series D Round Of $32 Million

Friday, April 20, 2007 5:00:00 AM PDT | VentureDeal Staff
HAYWARD, CA -- Metabolex, Inc. said that it raised a fourth round of venture capital, netting $32 million from a large group of VCs and private equity funds.

The company claims it has developed novel approaches to treatments for diabetes and related metabolic disorders and said it plans to use the funding proceeds to speed clinical testing of its dyslipidemia treatment.

Investors in the round were led by MPM BioEquities, and included AllianceBernstein, Deerfield Management, T. Rowe Price, Alta Partners, Bay City Capital, Biotech Turnaround Fund, Birchmere Ventures, Johnson & Johnson Development Corporation, KBC Funds, Merlin BioMed Group, Novo Ventures, VantagePoint Venture Partners, Venrock Partners and Versant Ventures.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1